CSWYY (China Shineway Pharmaceutical Group) Growth Rank: 9 (As of Jul. 13, 2026) — 125% Above Median


CSWYY China Shineway Pharmaceutical Group Ltd CSWYY
92 GF Score
Price $19.25
GF Value $16.74
! 2 Warning Signs
View Full Analysis

What is China Shineway Pharmaceutical Group Growth Rank?

China Shineway Pharmaceutical Group CSWYY 92 Growth Rank is 9 as of Jul. 13, 2026, which is 125% above its 10-year median of 4.00. GuruFocus rates CSWYY with a GF Score™ of 92/100 and a GF Value™ of $16.74. The stock has 2 warning signs investors should review.

China Shineway Pharmaceutical Group has the Growth Rank of 9.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

China Shineway Pharmaceutical Group Growth Rank Related Terms

CSWYY vs ZTS, UTHR: Growth Rank Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, China Shineway Pharmaceutical Group's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Shineway Pharmaceutical Group Growth Rank vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Shineway Pharmaceutical Group's Growth Rank distribution charts can be found below:

* The bar in red indicates where China Shineway Pharmaceutical Group's Growth Rank falls into.


CSWYY
92GF Score
China Shineway Pharmaceutical Group Ltd CSWYY
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 9 mean?
China Shineway Pharmaceutical Group (CSWYY) has a Growth Rank of 9 as of Jul. 13, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on China Shineway Pharmaceutical Group and its competitors. This is 125% above median its historical median of 4.00. Over the past decade, China Shineway Pharmaceutical Group's Growth Rank has ranged from 2.00 to 10.00.
Is China Shineway Pharmaceutical Group's Growth Rank too high?
China Shineway Pharmaceutical Group's current Growth Rank of 9 is 125% above median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 10.00. Overall, China Shineway Pharmaceutical Group has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does China Shineway Pharmaceutical Group's Growth Rank compare to ZTS and UTHR?
China Shineway Pharmaceutical Group's Growth Rank of 9 can be compared against companies in the Drug Manufacturers industry. Historically, China Shineway Pharmaceutical Group's own Growth Rank has ranged from 2.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Drug Manufacturers company?
A good Growth Rank depends on the Drug Manufacturers industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on China Shineway Pharmaceutical Group and its competitors. China Shineway Pharmaceutical Group's current Growth Rank is 9, which is 125% above median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Shineway Pharmaceutical Group stock overvalued right now?
China Shineway Pharmaceutical Group (CSWYY) has a current Growth Rank of 9. The stock's GF Value™ is $16.74, compared to a current price of $19.25 — trading 15% above its estimated fair value. The current Growth Rank is 9, which is 125% above median its 10-year median of 4.00. China Shineway Pharmaceutical Group's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For China Shineway Pharmaceutical Group (CSWYY), the current Growth Rank is 9 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Shineway Pharmaceutical Group (CSWYY) Overvalued in 2026?

Based on GuruFocus' analysis, China Shineway Pharmaceutical Group stock appears to be overvalued. The current stock price of $19.25 is trading 15% above its estimated GF Value™ of $16.74.

Key valuation signals for CSWYY:

  • Growth Rank: 9 (125% above median its 10-year median of 4.00)
  • GF Value™: $16.74 vs. price of $19.25 (15% above fair value)
  • GF Score™: 92/100 with 2 warning signs

No single metric tells the full story. See the CSWYY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

China Shineway Pharmaceutical Group Business Description

Other Exchanges 02877:Hong KongC1S:Germany
Address Luan Cheng, Hebei Province, Shijiazhuang, CHN
China Shineway Pharmaceutical Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, traditional Chinese medicine formula granules, and others, of which injections generate maximum revenue for the company. Geographically, the group operates in the People's Republic of China (PRC) and Hong Kong.
92GF Score

Get the complete analysis for CSWYY

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.25
Price
$16.74
GF Value